Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Warner Music Group Corp (WMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Warner Music Group Corp — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Warner Music Group Corp trades at $29.07 (market cap $15.12B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 2× Warner Music Group Corp's market cap, and Warner Music Group Corp pays the higher dividend (2.77%). Which is the better fit depends on your goals.
| GEHC | WMG | |
|---|---|---|
Market Cap | $30.93B | $15.12B |
Volume | 5,033,451 | 1,727,670 |
Sector | Health | Media |
52-Week High | $88.16 | $34.72 |
52-Week Low | $59.48 | $23.65 |
Enterprise Value | $39.39B | $19.42B |
Dividend Yield | 0.23% | 2.77% |
Typical Hold Time | — | 97 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Warner Music Group (WMG) trades at $28.91, up 0.91% on the day, with a bullish technical signal from moving averages. The stock shows strong analyst support with a consensus price target of $39.50, representing significant upside. Recent earnings have beaten expectations in two of the last three quarters, with Q3 2026 results pending. The company maintains robust profitability with a 45.77% gross margin and 9.2% net margin, while revenue growth continues steadily from $6.71B in 2025 to a projected $7.3B in 2026.
WMG presents a compelling investment case with strong fundamentals, positive analyst sentiment, and strategic positioning in the evolving music industry, particularly through AI partnerships. However, risks include recent leadership changes, ongoing copyright litigation, and valuation metrics that appear elevated relative to historical norms. The stock's current price near recent highs suggests limited near-term upside without further positive catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
